If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,056.00    22.00 (2.13%)
Bid:
1,060.00
Ask:
1,064.00
Spread: 4.00 (0.377%)
Market Cap: £151.30b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Early redemption ISIN ES0213770011

3 Sep 2024 17:06

RNS Number : 7687C
Banco Santander S.A.
03 September 2024
 

Banco Santander, S.A., in compliance with the Securities Market legislation, hereby communicates the following:

 

INSIDE INFORMATION

Banco Santander, S.A. (the "Issuer") hereby announces that, in relation to the following issuance: "First Issuance of Special Subordinated Debt of Banco Pastor, S.A." ("Primera Emisión de Deuda Subordinada Especial de Banco Pastor, S.A."), with ISIN code ES0213770011, for a total amount of three hundred million euros (EUR 300,000,000) and the Brief Informative Prospectus (Folleto Informativo Reducido) of which was registered with the registries of the Spanish National Securities Market Commission on 11 May 2004; it intends to carry out on 11 September 2024 the total early redemption of the issuance through the redemption at par of each and every one of the securities that compose the aforementioned issuance plus accrued and unpaid interest until the aforementioned redemption date.

 

Likewise, it is stated that all the necessary communications have been made to the corresponding organizations and media.

 

This is hereby reported as inside information for the appropriate purposes.

 

Boadilla del Monte (Madrid), 3 September 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

IMPORTANT INFORMATION

 

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIRAEIVIIS
Date   Source Headline
2nd Jul 202611:06 amRNSBuyback programme: transactions 25June-1July
30th Jun 20264:47 pmRNSTotal Voting Rights
25th Jun 202611:35 amRNSBuyback programme: transactions 18-24June
18th Jun 202611:05 amRNSBuyback programme: transactions 11-17June
11th Jun 202611:02 amRNSBuyback programme: transactions 4-10June
10th Jun 20268:35 amRNSResult of Tender Offer
5th Jun 20263:06 pmRNSDirector/PDMR Shareholding
4th Jun 202611:05 amRNSBuyback programme: transactions 28May-3June
1st Jun 20264:47 pmRNSTotal Voting Rights
28th May 20267:00 amRNSAT1s Contingent Convertible securities
27th May 20268:26 amRNSOffer to purchase outstanding instruments
27th May 20268:21 amRNSResumption of the share buyback programme
13th May 20263:03 pmRNSRating granted by Fitch Ratings
6th May 20263:08 pmRNSDirector/PDMR Shareholding
1st May 20267:08 amRNSFurther re: Santander to acquire TSB
30th Apr 20264:59 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNS1Q2026 Financial report & Earnings presentation
29th Apr 20267:00 amRNSFirst Quarter 2026 Results - Press release
24th Apr 202611:14 amRNSBuyback programme: transactions 16-23Apr
23rd Apr 20267:40 amRNSProspectus Exemption
23rd Apr 20267:25 amRNSTemporary suspension of the share buyback program
22nd Apr 202611:09 amRNS1st Quarter 2026 Results Notice
16th Apr 202611:04 amRNSBuyback programme: transactions 8-15Apr
14th Apr 20264:58 pmRNSSantander informs of the MREL determined by SRB
8th Apr 202611:07 amRNSBuyback programme: transactions 26Mar-7Apr
31st Mar 20264:44 pmRNSTotal Voting Rights
27th Mar 20262:26 pmRNS2026 AGM - Resolutions
27th Mar 20267:06 amRNSSantander expects higher profit&reaffirms targets
26th Mar 202610:12 amRNSBuyback programme: transactions 19-25Mar
19th Mar 20265:01 pmRNSDirector/PDMR Shareholding
19th Mar 202611:17 amRNSBuyback programme: transactions 12-18Mar
13th Mar 20264:37 pmRNSDirector/PDMR Shareholding
12th Mar 202611:10 amRNSBuyback programme: transactions 5-11Mar
9th Mar 202611:17 amRNSDirector/PDMR Shareholding
9th Mar 202611:14 amRNSDirector/PDMR Shareholding
6th Mar 20264:18 pmRNSDirector/PDMR Shareholding
5th Mar 202611:16 amRNSBuyback programme: transactions 27Feb-4Mar
4th Mar 20265:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:57 pmRNSTotal Voting Rights
27th Feb 202611:18 amRNSBuyback programme: transactions 19-26Feb
25th Feb 20266:01 pmRNSNotice of AGM
25th Feb 20265:20 pmRNS2025 UK Annual Report
25th Feb 20262:19 pmRNSInvestor Day: Group CFO presentation
25th Feb 202612:42 pmRNSInvestor Day: Group CEO presentation
25th Feb 202612:37 pmRNSInvestor Day: Executive chair presentation
25th Feb 20267:03 amRNSStrategic plans, profit forecasts & payout policy
25th Feb 20267:00 amRNSDividend declaration & agreement to call 2026 AGM
24th Feb 20263:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:54 pmRNSDirector/PDMR Shareholding
19th Feb 202611:29 amRNSBuyback programme: transactions 12-18Feb

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.